AI in clinical trial adherence and retention: is it a Pandora’s box?
Clinical Trials Arena demystifies how AI can potentially help participants stick to the study all the way to the end, while also pointing to clinical trial…
By
Follow @ufulti
Urtė Fultinavičiūtė is a healthcare reporter for Clinical Trials Arena. Urtė's coverage focuses on clinical data management and clinical strategy.
Clinical Trials Arena demystifies how AI can potentially help participants stick to the study all the way to the end, while also pointing to clinical trial…
By Urtė FultinavičiūtėData, proactively seeking innovation, and clear governance are key tools in future-proofing supply chains in clinical trials.
By Urtė FultinavičiūtėKinnov Therapeutics in alcohol addiction and Genmab in fallopian tube cancer are also reviewed by Clinical Trials Arena.
By Urtė FultinavičiūtėThe medical device study investigated Renovia’s Leva, designed to help users perform Kegels more effectively.
By Urtė FultinavičiūtėClinical Trials Arena also reviews other Phase I assets by Lumen Bioscience, Pfizer, and Lung Therapeutics.
By Urtė FultinavičiūtėExperts were less keen on variant-specific or multivariant Covid-19 vaccines owing to lack of practical value despite scientific rationale.
By Urtė FultinavičiūtėThe Clinical Trials Arena team also looks into Celyad in colorectal cancer after its Phase Ib termination.
By Urtė FultinavičiūtėMesoblast in ulcerative colitis and Sage in major depressive disorder are also reviewed by Clinical Trials Arena.
By Urtė FultinavičiūtėSocial media, earlier help-seeking, and worsening of symptoms due to lockdowns contribute to increase in eating disorder diagnosis.
By Urtė Fultinavičiūtė